What is Epic Pharma?
Epic Pharma is a prominent FDA-approved generic pharmaceutical company dedicated to the development, manufacturing, and distribution of high-quality, affordable medications. Their operations encompass the production of tablets, capsules, and powders, alongside offering robust contract manufacturing services. The company adheres to stringent quality control measures and regulatory compliance across its diverse product portfolio, which addresses key therapeutic areas such as cardiovascular, respiratory, and anti-infectives.
How much funding has Epic Pharma raised?
Epic Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Epic Pharma
PPP
Public-Private Partnership
What's next for Epic Pharma?
The recent major strategic investment signals a pivotal growth phase for Epic Pharma. This influx of capital is anticipated to fuel further expansion of its manufacturing capabilities, enhance its research and development pipeline for new generic formulations, and potentially broaden its market reach. The company's focus on affordable, high-quality medications positions it for continued success in the competitive pharmaceutical landscape, with strategic financing likely aimed at scaling operations and solidifying its market share.
See full Epic Pharma company page
